| Financial Year |
March 31 2023 |
| Monetary Funds |
4,674,235.45 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
5,256,354.59 |
| Accounts Receivable |
75,162,326.83 |
| Advances to Suppliers |
1,879,290.66 |
| Other Receivables |
809,626.19 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
9,860,359.52 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
673,603.29 |
| Total Current Assets |
107,392,636.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
6,430,495.97 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,141,000.28 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
3,035,050.49 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
15,704,230.32 |
| Total Assets |
123,096,866.38 |
| Short-Term Loans |
14,016,683.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
14,909,727.83 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,173,090.27 |
| Taxes Payable |
3,468,078.92 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
29,764,367.29 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,033,442.26 |
| Other Current Liabilities |
5,996,317.62 |
| Sub-Total of Current Liabilities |
73,984,621.17 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
800,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
168,022.66 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
4,620,224.78 |
| Total Liabilities |
78,604,845.95 |
| Paid-In Capital(Or Share Stock) |
195,600,000.00 |
| Capital Surplus |
228,747,351.80 |
| Surplus Reserve |
28,032,041.86 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-433,271,806.22 |
| Minority Stockholder's Interest |
25,195,700.68 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
19,296,319.75 |
| Owner's Equity（Stockholder's Equity） |
44,492,020.43 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
123,096,866.38 |
